{
  "id": 3045944,
  "title": "Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.",
  "url": "https://urgent.news/2026/08/24/billionaire-ken-griffin-just-loaded-up-on-abbvie-and-abbott-heres-3045944",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-24T14:35:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/billionaire-ken-griffin-just-loaded-abbvie-and-abbott-heres-whether-investors-should"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsHis purchases increased his exposure to pharmaceuticals, medical devices, diagnostics, and diabetes care.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.",
        "url": "https://urgent.news/2026/08/24/billionaire-ken-griffin-just-loaded-up-on-abbvie-and-abbott-heres",
        "published": "2026-08-24T14:15:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}